CANCELLED – SECTION 71
on 13 May 2022
Last Applicant/ Owned by
B-3001 Heverlee
BE
Serial Number
79093385 filed on 30th Nov 2010
Registration Number
4047607 registered on 01st Nov 2011
Filing Basis
No Filing Basis
Disclaimer
"THROMBOGENICS"
TG THROMBOGENICS
TG THROMBO GENICS The mark consists of the letters "TG" in grey and the word "thrombogenics" in red with a grey vertical line separating the literal elements of the mark. Pharmaceutical preparations for treatment of diseases and disorders, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for treatment of diseases and disorders, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; veterinary preparations for treatment of diseases and disorders in mammalians, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters; material for stopping teeth, dental wax; disinfectants for medical instruments, for hygienic purposes, and for use in medical surgery procedures; preparations for destroying vermin; fungicides, herbicides; biopharmaceutical preparations, namely, anticoagulants, anti angiogenic drugs, anticancer drugs, cardiovascular drugs, protease enzymes, protease inhibitors, antibodies, plasmins, truncated plasmins, microplasmins, plasminogens, truncated plasminogens, microplasminogens, plasminogen activators, staphylokinases for the treatment diseases and disorders, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; diagnostic medical reagents, chemicals and biological materials, namely, antigen and diagnostic kits consisting primarily of monoclonal and/or polyclonal antibodies, buffers, and reagents for medical laboratory use in disease testing
Class [001]
Chemical Products
Chemical preparations and substances for use in the manufacture of pharmaceuticals
Class [042]
Computer & Software Services & Scientific Services
Scientific and technological services, namely, scientific research and design of new products in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention, and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; industrial analysis and product research services in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; pharmaceutical, biopharmaceutical, medical, biomedical, biological, biochemical, toxicological and clinical research and product development of diagnostic tests and kits, biopharmaceutical preparations and drugs, and medicines; biopharmaceutical product evaluation; biological, biochemical, pharmaceutical, medical, toxicological and clinical research, scientific research for medical purposes in the treatment of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer diseases and disorders; development services in the field of new biopharmaceutical drugs, preparations and medicines for ophthalmic, vascular and cancer pathologies
Class [044]
Medical, Beauty & Agricultural Services
Medical services; veterinary services; medical, veterinary and pharmaceutical advisory and consultancy services; medical services, namely, therapeutic, prognostic and diagnostic testing services
Mark Details
Serial Number
No 79093385
Mark Type
No Service Mark
Attorney Docket Number
No NO30163TUS
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.17.08 -
A single line, band, bar or diagonal
Description of Design Search
The mark consists of the letters "TG" in grey and the word "thrombogenics" in red with a grey vertical line separating the literal elements of the mark.
Legal History
| Status Date | Action Taken |
|---|---|
| 11th Apr 2023 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 01st Mar 2023 | INVALIDATION PROCESSED |
| 01st Mar 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 13th Jan 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 13th May 2022 | CANCELLED SECTION 71 |
| 17th Dec 2020 | INTERNATIONAL REGISTRATION RENEWED |
| 01st Nov 2020 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| 13th Jun 2019 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 08th Mar 2019 | PARTIAL INVALIDATION PROCESSED BY THE IB |
| 26th Jan 2019 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |